IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling

Emerging evidence has demonstrated that inflammation is involved in the occurrence and development of diabetic neuropathic pain (DNP). The anti-inflammatory property of interleukin (IL)-35 makes it a promising...

Source: Journal of Inflammation - July 23, 2019 Category: Allergy & Immunology Authors: Yinghai Jiang, Jing Wang, Haiqin Li and Lingjie Xia Tags: Research Source Type: research